Synopsis
We focus on patients, typically children, with rare, undiagnosed disorders. We try to identify their disease causing mutations, usually in new genes. Over the years we employed different technologies; now we are at the era of the EXOME. We developed tools to analyze exome analyses. On good days, we find a new gene, and link it to a disease in human. We annotate the genes and name the genetic disorders, paving the way for future cure.